JINS HOLDINGS Inc. (TYO:3046)
8,630.00
-170.00 (-1.93%)
Apr 24, 2025, 3:30 PM JST
JINS HOLDINGS Revenue
JINS HOLDINGS had revenue of 23.78B JPY in the quarter ending February 28, 2025, with 19.77% growth. This brings the company's revenue in the last twelve months to 89.81B, up 17.06% year-over-year. In the fiscal year ending August 31, 2024, JINS HOLDINGS had annual revenue of 83.00B with 13.29% growth.
Revenue (ttm)
89.81B
Revenue Growth
+17.06%
P/S Ratio
2.24
Revenue / Employee
25.77M
Employees
3,485
Market Cap
201.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Aug 31, 2024 | 83.00B | 9.74B | 13.29% |
Aug 31, 2023 | 73.26B | 6.36B | 9.51% |
Aug 31, 2022 | 66.90B | 3.00B | 4.70% |
Aug 31, 2021 | 63.90B | 3.64B | 6.04% |
Aug 31, 2020 | 60.26B | -1.64B | -2.64% |
Aug 31, 2019 | Pro | Pro | Pro |
Aug 31, 2018 | Pro | Pro | Pro |
Aug 31, 2017 | Pro | Pro | Pro |
Aug 31, 2016 | Pro | Pro | Pro |
Aug 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 838.60B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Shionogi & | 456.87B |